We consistently evaluate our products in the clinical setting.
Continued
clinical studies
Even though Ethicon no longer sells GYNECARE PROLIFT®, clinical studies continue to report on the safety and efficacy of the procedure.
Preferred option
for millions
seeking to improve their quality of life
Surgery with implantable mesh is backed by years of clinical research, has undergone rigorous regulatory reviews and has been the preferred option for millions of women seeking to improve their quality of life.
Most important advancement in
the treatment of SUI in the last
50 years
“[the polypropylene midurethral sling] procedure is probably the most important advancement in the treatment of stress urinary incontinence in the last 50 years and has the full support of our organizations which are dedicated to improving the lives of women with urinary incontinence.”
According to a February 2018 position statement supported by the American Urogynecologic Society, the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the International Urogynecological Association, the American Association of Gynecological Laparoscopists, the American College of Obstetricians and Gynecologists, the Society of Gynecologic Surgeons, and the National Association for Continence
TVT is a
highly effective
and safe option for the treatment of SUI
“The 17-year results of this study showed that TVT™ is a highly effective and safe option for the treatment of SUI."
British Medical Journal, 2018
SCENIHR supports
continuing
synthetic sling use for SUI
“However, synthetic sling SUI surgery is an accepted procedure with proven efficacy and safety in the majority of patients with moderate to severe SUI, when used by an experienced and appropriately trained surgeon. Therefore, the SCENIHR supports continuing synthetic sling use for SUI, but emphasizes the importance of appropriately trained surgeons and detailed counselling of patients about the associated risk/benefits."
EU Scientific Committee On Emerging And Newly Identified Health Risks
December 2015 | SOURCE
Use of mesh to treat women with SUI and POP
is a safe option
for women
“The use of mesh to treat women with SUI and POP is a safe option for women.”
“For many women suffering the distressing effects of SUI and POP, surgical procedures using mesh devices have provided an effective form of treatment which can be far less invasive than alternative surgical procedures."
NHS England Mesh Oversight Group July 2017 | SOURCE
women must be offered all
appropriate
treatments
(mesh and nonmesh)
“In the case of surgical treatment for SUI, a review of the different sources of evidence has led us to recommend that women must be offered all appropriate treatments (mesh and nonmesh) as well as the information to make informed choices."
Scottish Government Independent Review Group March 2017 | SOURCE
the most extensively researched
surgical treatment
for SUI
“Mid-urethral sling operations have been the most extensively researched surgical treatment for stress urinary incontinence (SUI) in women and have a good safety profile. Irrespective of the routes traversed, they are highly effective in the short and medium term, and accruing evidence demonstrates their effectiveness in the long term."
Cochrane July 2015 | SOURCE
evidence supports the use of
these devices in
the UK
“What we continue to see is that evidence supports the use of these devices in the UK for treatment of the distressing conditions of incontinence and organ prolapse in appropriate circumstances. This is supported by the greater proportion of the clinical community and patients."
UK Medicines and Healthcare Products Regulatory Agency
October 2017 | SOURCE
No other surgical treatment for SUI before
or since has been subject to such
extensive
investigation
"Among historical SUI procedures, the midurethral sling has been studied as long in follow-up after implantation as any other procedure and has demonstrated superior safety and efficacy. No other surgical treatment for SUI before or since has been subject to such extensive investigation.”
Joint Statement by numerous organizations, including the American Urogynecologic Society, the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction, the American College of Obstetricians and Gynecologists, the International Urogynecological Association, the Society of Gynecologic Surgeons, and the American Association of Gynecological Laparoscopists February 2018 | SOURCE
The polypropylene midurethral sling has helped
millions of women
with SUI regain control of their lives
“The polypropylene midurethral sling has helped millions of women with SUI regain control of their lives by undergoing a simple outpatient procedure that allows them to return to daily life very quickly. With its acknowledged safety and efficacy it has created an environment for a much larger number of women to have access to treatment.”
The American Urogynecologic Society and the Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction 2014 position statement | SOURCE